Asset
Imdusiran Sodium
Assembly Biosciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04820686 | phase2 | terminated | 2021-05-07 | 2023-03-30 | Assembly Biosciences | A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection |
FDA applications (0)
This company has no applications containing this asset.